This grant is for advancing synthetic nucleic acid platforms, designed to enable the rapid development and iterative testing of active and passive immunization strategies. Specifically, it targets HIV prevention, treatment, and cure, aiming to significantly accelerate research in this critical area. The funding mechanism is a milestone-driven, biphasic award, meaning progress is evaluated at key stages. Eligibility for the second phase of funding is directly dependent on the successful achievement of predetermined milestones. This structured approach ensures focused and effective advancement towards innovative solutions for combating HIV.
Opportunity ID: 347676
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-23-026 |
Funding Opportunity Title: | Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 20, 2023 |
Last Updated Date: | Apr 20, 2023 |
Original Closing Date for Applications: | Aug 02, 2023 |
Current Closing Date for Applications: | Aug 02, 2023 |
Archive Date: | Sep 07, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) Small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to advance synthetic nucleic acid platforms for the rapid development and iterative testing of active and passive immunization strategies for HIV prevention, treatment, and cure. This funding opportunity will use a milestone-driven, biphasic award mechanism. Transition to the second phase will depend on the successful completion of milestones. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-026.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 347676 Full Announcement-RFA-AI-23-026 -> RFA-AI-23-026-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281281 | Jul 02, 2023 | Aug 02, 2023 | View |
Package 1
Mandatory forms
347676 RR_SF424_5_0-5.0.pdf
347676 PHS398_CoverPageSupplement_5_0-5.0.pdf
347676 RR_OtherProjectInfo_1_4-1.4.pdf
347676 PerformanceSite_4_0-4.0.pdf
347676 RR_KeyPersonExpanded_4_0-4.0.pdf
347676 RR_Budget_3_0-3.0.pdf
347676 PHS398_ResearchPlan_5_0-5.0.pdf
347676 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347676 RR_SubawardBudget30_3_0-3.0.pdf
347676 PHS_AssignmentRequestForm_3_0-3.0.pdf